Clinical Trial Update: Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the immunogenicity of a 13-valent pneumococcal conjugate vaccine compared with the pneumococcal polysaccharide vaccine in adult kidney …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• 13-valent pneumococcal conjugate vaccine (13-valent pneumococcal conjugate vaccine)
• Pneumococcal polysaccharide vaccine (pneumococcal polysaccharide vaccine)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Kidney Transplantation, Liver Transplantation | Phase 4 | Status: COMPLETED